Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Taste Masking
Chewable & Orodispersible Aids
Direct Compression
Parenteral
Disintegrants & Superdisintegrants
Co-Processed Excipients
Solubilizers
Thickeners and Stabilizers
Granulation
Surfactant & Foaming Agents
Coating Systems & Additives
Topical
Emulsifying Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
100
PharmaCompass offers a list of Semaxanib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Semaxanib manufacturer or Semaxanib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Semaxanib manufacturer or Semaxanib supplier.
PharmaCompass also assists you with knowing the Semaxanib API Price utilized in the formulation of products. Semaxanib API Price is not always fixed or binding as the Semaxanib Price is obtained through a variety of data sources. The Semaxanib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Semaxanib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Semaxanib, including repackagers and relabelers. The FDA regulates Semaxanib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Semaxanib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Semaxanib supplier is an individual or a company that provides Semaxanib active pharmaceutical ingredient (API) or Semaxanib finished formulations upon request. The Semaxanib suppliers may include Semaxanib API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Semaxanib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Semaxanib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Semaxanib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Semaxanib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Semaxanib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Semaxanib suppliers with NDC on PharmaCompass.
Semaxanib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Semaxanib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Semaxanib GMP manufacturer or Semaxanib GMP API supplier for your needs.
A Semaxanib CoA (Certificate of Analysis) is a formal document that attests to Semaxanib's compliance with Semaxanib specifications and serves as a tool for batch-level quality control.
Semaxanib CoA mostly includes findings from lab analyses of a specific batch. For each Semaxanib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Semaxanib may be tested according to a variety of international standards, such as European Pharmacopoeia (Semaxanib EP), Semaxanib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Semaxanib USP).
